Pharmafile Logo

WG Consulting

The WG Group provides bespoke Market Access consultancy services for all healthcare stakeholders. These include the pharmaceutical, medical devices and diagnostics industries, the independent sector, European state healthcare providers and academia. Its unique blend of experience and expertise enables the WG Group to provide innovative solutions effectively tailored to clients’ needs. The WG Group is part of the Grey Healthcare Group, one of the world’s largest healthcare communications agency networks and part of the WPP Group of companies which gives our clients access to an unparalleled breadth of global expertise.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

WG House, 2 Cressex Road, High Wycombe, Buckinghamshire, HP12 4TY, United Kingdom
+44 (0)1494 470760

 Latest Content from PMHub 

Rare Disease Day in a COVID-19 environment

For many people and families living with a rare disease, their journey can be very complex. At times, that journey can even be scary, frustrating and confusing. However, when your...

Bedrock’s strong start to 2021

Just two months into the year and at Bedrock we’ve already added FOUR new people to an ever-growing team!

Enabling Patient-Focused Research Through Virtual Clinical Trials

Videos and Podcasts | February 25, 2021 | Impetus Digital

Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital...

Innovative Approaches to Managing Mental Health Conditions

Videos and Podcasts | February 25, 2021 | Impetus Digital

Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and...

Newcells Biotech secures over £5m for 3D tissue models

Press Releases | February 25, 2021 | Onyx Health

Newcells Biotech have received multi-million investment to develop their pioneering 3D tissue models

Why we need to look at rare diseases in a different way

28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.

Why we need to look at rare diseases in a different way

28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.

Looking back at the year when everything changed

COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families.

Rare Disease Day – why it’s important to show your stripes

Press Releases | February 23, 2021 | Nucleus Global

Nucleus Global's EU Strategy Director, Amanda Henkel, writes about the importance of continuing to raise awareness of rare diseases